Bispecific Antibodies: The Next Generation of Immunotherapy
Pharmacy Times,
The use of immunotherapy to kill cancer cells was proposed many decades ago but has only recently been realized as a…
The use of immunotherapy to kill cancer cells was proposed many decades ago but has only recently been realized as a…
Summary Aptevo went up hugely on positive phase 1 data in AML. The company develops bispecific antibodies against cancer.
Feb 19 · 5 min read Innovations in mRNA technology can help fulfill the huge promise of bispecific antibodies as cancer…